Evgenia Aga

2.9k total citations
32 papers, 1.5k citations indexed

About

Evgenia Aga is a scholar working on Virology, Infectious Diseases and Emergency Medicine. According to data from OpenAlex, Evgenia Aga has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Virology, 24 papers in Infectious Diseases and 7 papers in Emergency Medicine. Recurrent topics in Evgenia Aga's work include HIV Research and Treatment (29 papers), HIV/AIDS Research and Interventions (21 papers) and HIV/AIDS drug development and treatment (16 papers). Evgenia Aga is often cited by papers focused on HIV Research and Treatment (29 papers), HIV/AIDS Research and Interventions (21 papers) and HIV/AIDS drug development and treatment (16 papers). Evgenia Aga collaborates with scholars based in United States, India and Malawi. Evgenia Aga's co-authors include Ronald J. Bosch, John W. Mellors, Rajesh T. Gandhi, Daniel R. Kuritzkes, Michael M. Lederman, Joseph J. Eron, Michael F. Para, Feiyu Hong, Guillaume Besson and Jonathan Z. Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Evgenia Aga

30 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evgenia Aga United States	16	1.2k	983	451	262	179	32	1.5k
Riddhima Banga Switzerland	11	660 0.6×	344 0.3×	538 1.2×	202 0.8×	106 0.6×	17	960
Lawrence Fox United States	22	1.2k 1.0×	919 0.9×	589 1.3×	532 2.0×	285 1.6×	41	1.8k
Elisa De Crignis Italy	16	712 0.6×	359 0.4×	503 1.1×	173 0.7×	307 1.7×	28	1.2k
Camille Lécuroux France	19	707 0.6×	395 0.4×	478 1.1×	174 0.7×	186 1.0×	33	935
Lucia Ometto Italy	18	635 0.5×	444 0.5×	295 0.7×	253 1.0×	93 0.5×	26	898
Andrea Stacey United Kingdom	11	590 0.5×	310 0.3×	468 1.0×	292 1.1×	131 0.7×	16	1.0k
Mariam B. Lawani United States	7	590 0.5×	312 0.3×	431 1.0×	174 0.7×	75 0.4×	7	787
Anni Winckelmann Denmark	12	718 0.6×	544 0.6×	310 0.7×	154 0.6×	65 0.4×	20	938
M. Shirin Sabbaghian United States	11	1.5k 1.2×	537 0.5×	1.4k 3.0×	356 1.4×	69 0.4×	15	2.0k
Marisa Zanchetta Italy	22	541 0.5×	430 0.4×	291 0.6×	378 1.4×	144 0.8×	45	1.2k

Countries citing papers authored by Evgenia Aga

Since Specialization

Citations

This map shows the geographic impact of Evgenia Aga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evgenia Aga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evgenia Aga more than expected).

Fields of papers citing papers by Evgenia Aga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evgenia Aga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evgenia Aga. The network helps show where Evgenia Aga may publish in the future.

Co-authorship network of co-authors of Evgenia Aga

This figure shows the co-authorship network connecting the top 25 collaborators of Evgenia Aga. A scholar is included among the top collaborators of Evgenia Aga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evgenia Aga. Evgenia Aga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bullotta, Arlene, Evgenia Aga, Ronald J. Bosch, et al.. (2024). Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral Therapy. The Journal of Immunology. 212(10). 1564–1578. 1 indexed citations

Aga, Evgenia, et al.. (2024). Prevalence and Psychological Stress in Oral Aphthous Ulcers among Dental Students at the University of Tripoli. 16–21.

Moser, Carlee, Jonathan Z. Li, Joseph J. Eron, et al.. (2022). 1063. Female sex and SARS-CoV-2 Serostatus Predict Nasopharyngeal RNA Clearance during Early COVID-19. Open Forum Infectious Diseases. 9(Supplement_2).

Hong, Feiyu, Jana L. Jacobs, Evgenia Aga, et al.. (2018). Associations between HIV-1 DNA copy number, proviral transcriptional activity, and plasma viremia in individuals off or on suppressive antiretroviral therapy. Virology. 521. 51–57. 15 indexed citations

Park, You Jeong, Behzad Etemad, Hayat Ahmed, et al.. (2017). Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption. SHILAP Revista de lepidopterología. 2(3). 431–431. 10 indexed citations

Hong, Feiyu, Evgenia Aga, Anthony R. Cillo, et al.. (2016). Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA. Journal of Clinical Microbiology. 54(4). 902–911. 83 indexed citations

Li, Jonathan Z., Behzad Etemad, Hayat Ahmed, et al.. (2015). The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption. AIDS. 1–1. 189 indexed citations

Riddler, Sharon A., Evgenia Aga, Ronald J. Bosch, et al.. (2015). Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1–Infected Adults Receiving Long-term Antiretroviral Therapy. The Journal of Infectious Diseases. 213(4). 556–560. 37 indexed citations

Besson, Guillaume, Christina M. Lalama, Ronald J. Bosch, et al.. (2014). HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy. Clinical Infectious Diseases. 59(9). 1312–1321. 164 indexed citations

10.

Wallis, Carole L., Evgenia Aga, Heather J. Ribaudo, et al.. (2014). Drug Susceptibility and Resistance Mutations After First-Line Failure in Resource Limited Settings. Clinical Infectious Diseases. 59(5). 706–715. 32 indexed citations

11.

Bartlett, John, Heather J. Ribaudo, Carole L. Wallis, et al.. (2012). Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. AIDS. 26(11). 1345–1354. 32 indexed citations

12.

Bosch, Ronald J., Richard B. Pollard, Alan Landay, Evgenia Aga, & Lawrence Fox. (2011). A Randomized Trial of Interleukin-2 During Withdrawal of Antiretroviral Treatment. Journal of Interferon & Cytokine Research. 31(6). 481–483. 4 indexed citations

13.

Connick, Elizabeth, et al.. (2011). Augmented HIV-Specific Interferon-Gamma Responses, But Impaired Lymphoproliferation During Interruption of Antiretroviral Treatment Initiated in Primary HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(1). 1–8. 7 indexed citations

14.

Taiwo, Babafemi, Sébastien Gallien, Evgenia Aga, et al.. (2011). Antiretroviral Drug Resistance in HIV-1–Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy. The Journal of Infectious Diseases. 204(4). 515–520. 105 indexed citations

15.

Volberding, Paul A., Lisa M. Demeter, Ronald J. Bosch, et al.. (2009). Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS. 23(15). 1987–1995. 55 indexed citations

16.

Gandhi, Rajesh T., Ronald J. Bosch, Evgenia Aga, et al.. (2009). No Evidence for Decay of the Latent Reservoir in HIV‐1–Infected Patients Receiving Intensive Enfuvirtide‐Containing Antiretroviral Therapy. The Journal of Infectious Diseases. 201(2). 293–296. 59 indexed citations

17.

Kilby, J Michael, R. Pat Bucy, Donna Mildvan, et al.. (2006). A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV‐Specific Immunizations, and Interleukin‐2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024). The Journal of Infectious Diseases. 194(12). 1672–1676. 60 indexed citations

18.

Smith, Kimberly Y., Evgenia Aga, Ronald J. Bosch, et al.. (2004). Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy. AIDS. 18(14). 1953–1956. 31 indexed citations

19.

Sha, Beverly E., Michelle Onorato, John Bartlett, et al.. (2004). Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12. AIDS. 18(8). 1203–1206. 9 indexed citations

20.

Wallis, Robert S., Robert C. Kalayjian, Jeffrey M. Jacobson, et al.. (2003). A Study of the Immunology, Virology, and Safety of Prednisone in HIV-1–Infected Subjects with CD4 Cell Counts of 200 to 700 mm−3. JAIDS Journal of Acquired Immune Deficiency Syndromes. 32(3). 281–286. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact